US Stock MarketDetailed Quotes

ENVB Enveric Biosciences

Watchlist
  • 0.9800
  • +0.0545+5.89%
Close May 3 16:00 ET
  • 0.9600
  • -0.0200-2.04%
Post 19:48 ET
7.15MMarket Cap-121P/E (TTM)

About Enveric Biosciences Company

Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.

Company Profile

SymbolENVB
Company NameEnveric Biosciences
Listing DateNov 17, 2017
Issue Price4.12
Founded1994
CEODr. Joseph Tucker, PhD
MarketNASDAQ
Employees7
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address4851 Tamiami Trail NorthSuite 200
CityNaples
ProvinceFlorida
CountryUnited States of America
Zip Code34103
Phone1-239-302-1707
Websitehttp://www.enveric.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Joseph Tucker, PhD
  • Chief Executive Officer and Director
  • 577.07K
  • Dr. Peter Facchini, PhD
  • Chief Innovation Officer
  • 282.06K
  • Dr. Bob Dagher
  • Chief Medical Officer
  • --
  • Kevin M. Coveney
  • Principal Financial and Accounting Officer
  • 358.68K
  • Lynn Gallant
  • Vice President, Clinical Operations
  • --
  • Michael D. Webb
  • Chairman of the Board
  • 175.00K
  • Sheila DeWitt
  • Director
  • --
  • Dr. Douglas Lind
  • Independent Director
  • 39.00K
  • Frank Pasqualone
  • Independent Director
  • 57.50K
  • Dr. Marcus Schabacker, M.D.,PhD
  • Independent Director
  • 52.00K
  • George Kegler
  • Independent Director
  • 59.00K
  • Bevin O’Neil
  • Independent Director
  • 39.38K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg